🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/11/2024 | 97,92 | 97,92 | 94,48 | 96,31 | -2,08% | 3,51% | 16.464.500 |
| 14/11/2024 | 99,18 | 99,40 | 97,95 | 98,36 | -0,14% | 1,46% | 8.704.500 |
| 13/11/2024 | 98,51 | 99,45 | 97,90 | 98,50 | -0,08% | 1,57% | 8.869.700 |
| 12/11/2024 | 100,76 | 100,77 | 98,50 | 98,58 | -2,13% | 2,25% | 12.282.900 |
| 11/11/2024 | 102,53 | 103,40 | 100,46 | 100,73 | -2,13% | 2,87% | 10.075.300 |
| 08/11/2024 | 101,48 | 103,23 | 101,00 | 102,92 | +1,73% | 2,20% | 9.208.000 |
| 07/11/2024 | 101,44 | 101,69 | 100,85 | 101,17 | +0,44% | 0,83% | 8.676.100 |
| 06/11/2024 | 103,18 | 103,23 | 100,60 | 100,73 | -0,91% | 2,55% | 9.551.300 |
| 05/11/2024 | 101,36 | 101,73 | 100,52 | 101,65 | -0,22% | 1,19% | 6.741.400 |
| 04/11/2024 | 102,00 | 102,53 | 100,95 | 101,87 | -0,01% | 1,55% | 9.182.600 |
| 01/11/2024 | 101,78 | 102,72 | 101,21 | 101,88 | -0,43% | 1,48% | 10.180.600 |
| 31/10/2024 | 100,93 | 103,23 | 98,60 | 102,32 | -2,39% | 4,59% | 17.413.100 |
| 30/10/2024 | 103,46 | 105,00 | 102,90 | 104,83 | +1,06% | 2,03% | 13.897.200 |
| 29/10/2024 | 104,32 | 105,11 | 103,70 | 103,73 | -0,48% | 1,35% | 9.296.200 |
| 28/10/2024 | 104,60 | 105,00 | 103,93 | 104,23 | +0,24% | 1,02% | 6.968.900 |
| 25/10/2024 | 106,49 | 106,49 | 103,86 | 103,98 | -1,79% | 2,47% | 9.625.500 |
| 24/10/2024 | 106,05 | 106,62 | 105,26 | 105,88 | -0,47% | 1,28% | 8.295.900 |
| 23/10/2024 | 106,74 | 107,36 | 106,20 | 106,38 | -0,24% | 1,09% | 8.271.700 |
| 22/10/2024 | 105,91 | 106,90 | 105,71 | 106,64 | +0,28% | 1,12% | 11.576.100 |
| 21/10/2024 | 109,08 | 109,17 | 106,18 | 106,34 | -2,17% | 2,74% | 11.444.900 |
| 18/10/2024 | 109,90 | 109,92 | 108,56 | 108,70 | -0,96% | 1,24% | 9.523.000 |
| 17/10/2024 | 110,14 | 110,19 | 109,50 | 109,75 | -0,61% | 0,63% | 8.541.700 |
| 16/10/2024 | 111,00 | 111,20 | 109,02 | 110,42 | -1,00% | 1,96% | 8.729.200 |
| 15/10/2024 | 109,96 | 111,58 | 109,89 | 111,53 | +1,68% | 1,54% | 9.109.500 |
| 14/10/2024 | 109,43 | 110,07 | 108,68 | 109,69 | -0,04% | 1,27% | 8.130.700 |
| 11/10/2024 | 109,10 | 109,92 | 107,90 | 109,73 | +0,30% | 1,85% | 8.578.400 |
| 10/10/2024 | 110,70 | 110,83 | 109,17 | 109,40 | -0,79% | 1,50% | 6.006.700 |
| 09/10/2024 | 108,41 | 110,30 | 108,20 | 110,27 | +1,61% | 1,94% | 8.627.800 |
| 08/10/2024 | 107,97 | 108,75 | 107,81 | 108,52 | -0,06% | 0,87% | 8.832.400 |
| 07/10/2024 | 109,70 | 110,98 | 108,18 | 108,59 | -1,07% | 2,55% | 8.654.800 |